Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market

2025-12-19 14:42:34 ET

The last time I spoke about Sagimet Biosciences Inc. ( SGMT ) it was in a Seeking Alpha article entitled "Sagimet: Positive China Partner Acne Vulgaris Data Bodes Well For TVB-3567." With respect to this article, I noted that its partner Ascletis reported positive results from its phase 3 study using denifanstat for the treatment of patients with moderate-to-severe acne. The point here being that the mechanism of action [MOA] of a fatty acid synthetase inhibitor being able to treat these patients has been proven....

Read the full article on Seeking Alpha

For further details see: